- Earth
Science Tech, via its subsidiaries, centers on developing its role as a
global leader in the cannabinoid arena
- The company’s
diverse subsidiaries offer a wide selection of cannabinoid products in
numerous categories
- Earth
Science Tech recently announced a CBD/Propovit throat spray formula
developed via its partnership with Bionatus
A biotechnology enterprise, Earth Science Tech, Inc. (OTCQB:
ETST) focuses on cannabis (industrial hemp) and cannabinoid research and
development, nutraceuticals, pharmaceuticals and medical devices. The company
does so through its diverse wholly owned subsidiaries, which concentrate on the
development of Earth Science Tech’s role as a worldwide leader in the
cannabinoid space. Earth Science Tech is headquartered in Doral, Florida.
The company’s subsidiaries include Earth Science
Pharmaceutical, Inc.; Cannabis Therapeutics, Inc.; and KannaBidioiD, Inc. Earth
Science Tech’s Canadian subsidiary is Canna Inno Laboratories, Inc. Through its
subsidiaries, the company’s cannabinoid products are offered in different forms
of personal care goods, homeopathies, vitamins, minerals, herbs, botanicals, functional
foods and more (http://ibn.fm/QuWmD).
Subsidiary Earth Science Pharmaceutical focuses on becoming
a global leader in the development of low cost, non-invasive diagnostic tools,
medical devices, testing processes and vaccines for sexually transmitted
infections and/or diseases (STIs). The Cannabis Therapeutics subsidiary is
positioning itself to become an international leader in cannabinoid research
and development for a wide-ranging line of cannabinoid-based pharmaceuticals,
nutraceuticals and other products and solutions.
Earth Science Tech’s KannaBidioiD subsidiary focuses on
manufacturing and distributing vapes/e-liquids and gummy edibles in the
recreational arena formulated by its innovative Kanna and cannabinoid formula.
Moreover, the Canna Inno Laboratories subsidiary gives Earth Science Tech a
position in the Province of Québec. Canna Inno provides the company with access
to government grants, with the first now receiving approval.
Recently, Earth Science Tech announced that the new genuine
CBD/Propovit throat spray formula developed via a strategic partnership with
Bionatus is almost market-ready. The company worked together with Bionatus to
improve the Propovit throat spray. The outcome of this collaboration is a
strawberry-flavored formulation enriched with Earth Science Tech full-spectrum
cannabinoids obtained from industrial hemp (http://ibn.fm/gpU1W).
The principal active ingredient in Propovit is propolis.
This compound comes from the Brazilian green bee. Propolis has substantial
strong antioxidants. It also has potent anti-bacterial, anti-viral, anti-fungal
and anti-inflammatory properties. This new formulation unites the effect of
Propovit and the company’s cannabinoids to help reduce the symptoms of throat
infections. Fine drops distribute the hemp oil extensively onto the oromucosal
area of the mouth.
In a news release, Dr. Michel Aube, chief executive officer
and chief science officer of Earth Science Tech, stated, “We are very excited
to see this project in the final stage. We have developed a product that we
believe will have properties not found in any other product on the market, and
we thank our team and our partner Bionatus for their diligence and innovation
on this formulation.”
Earth Science Tech, by way of its subsidiaries, continues to
innovate and advance new initiatives in the cannabinoid space. It is working to
bring to market pioneering pharmaceutical and medical device offerings. For
investors, Earth Science Tech offers the opportunity for growth through its
varied portfolio and pipeline as it looks to expand its role as a leader in
diverse market sectors.
For more information, visit the company’s website at www.EarthScienceTech.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
